Greg Patterson
Director/Board Member bei DEVERON CORP.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Greg Patterson is the founder of A&L Canada Laboratories, Inc. He currently holds a position as Director at Deveron Corp.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DEVERON CORP.
8,75% | 29.12.2023 | 13 688 182 ( 8,75% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Greg Patterson
| Unternehmen | Position | Beginn |
|---|---|---|
| DEVERON CORP. | Director/Board Member | 20.05.2022 |
A&L Canada Laboratories, Inc.
 A&L Canada Laboratories, Inc. Medical/Nursing ServicesHealth Services Part of Deveron Corp., A&L Canada Laboratories, Inc. provides testing laboratory services. The private company is based in London, Canada. A&L Canada Laboratories was acquired by Deveron Corp. from 2736130 Ontario, Inc. on May 20, 2022 for $37.69 million. The Canadian company was founded by Greg Patterson. Greg Patterson has been the CEO since incorporation. | Chief Executive Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DEVERON CORP. | Technology Services |
| Private Unternehmen | 1 |
|---|---|
A&L Canada Laboratories, Inc.
A&L Canada Laboratories, Inc. Medical/Nursing ServicesHealth Services Part of Deveron Corp., A&L Canada Laboratories, Inc. provides testing laboratory services. The private company is based in London, Canada. A&L Canada Laboratories was acquired by Deveron Corp. from 2736130 Ontario, Inc. on May 20, 2022 for $37.69 million. The Canadian company was founded by Greg Patterson. Greg Patterson has been the CEO since incorporation. | Health Services |
